📌 Original Insight Summary

🧬 Healthcare & Pharma

• Eli Lilly (#LLY) Q1 2026 print confirms real demand, but the key overhang is pricing durability. Demand supports valuation. Pricing defines the risk. Until those two forces break one way, the right playbook is model discipline: strip out tailwinds, keep the watchlist tight, and let the next two or three quarters settle the debate. 1

🤖 AI Infrastructure & Cloud

• $ORCL looks early in one of the world’s biggest AI infrastructure buildouts. If OCI keeps growing near current rates, cloud growth pushes above 50%, and customer prepayments ease the funding burden, this selloff could end up looking like the painful capex/funding phase before the payoff. 2

• $NVDA has a key line in the sand: unless it closes above $205.10 on Friday, it will finish down 4 weeks in a row. The last 5-week losing streak came at the Sept-Oct 2022 absolute lows, making next week’s setup worth watching for potential exhaustion/inflection. 3

📊 ETF & Income Strategy

• Covered Call ETFs are being stress-tested against 2026 YTD benchmarks: S&P 500 +6%, Nasdaq +13%. Within the group, GPIQ +11.5% leads clearly, followed by QQQI +6.7%, GPIX +6.3%, QDVO +5.2%, and JEPQ +4.5%. Bottom line: GPIQ remains the standout Covered Call ETF in U.S. equities. 4

🚀 Momentum & Single-Name Setups

• $RKLB is being framed as ready for a bounce. Clean tactical call. The setup is about short-term mean reversion rather than a full fundamental re-rating. 5

• $SLB Schlumberger carries a bullish read. The signal is directional rather than deeply argued, but the stance is clear: energy services risk/reward is leaning long. 6

• 风华高科 is showing stronger price action than 6981 and 6976. Relative strength is the edge here: price is already voting before the broader narrative catches up. 7

🌏 Macro Regime & Long-Term Risk

• Recent U.S. core CPI, China inflation, and trade data point to the same macro regime: AI semiconductors are still driving production-goods inflation, while global consumption remains structurally weak. The bigger risk is an “Engels stagnation” setup over the next 5-10 years—a long-term drag on economies, societies, and even equity markets. Developed markets are already alert to it, but China’s exposure looks materially larger. 8